Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Tomas Orozco, Executive Vice President of Consumer Care at NeueHealth, Inc. (NASDAQ:NEUE), recently sold shares of the company’s common stock in transactions valued at approximately $4,599. The sales, disclosed in a recent SEC filing, occurred on March 7 and March 10, 2025, with prices ranging from $7.06 to $7.19 per share. The stock currently trades at $6.93, with InvestingPro analysis suggesting the company is undervalued despite its strong 27% gain over the past six months.
In the first transaction on March 7, Orozco sold 620 shares, and in a subsequent transaction on March 10, he sold an additional 20 shares. These sales were made to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by Orozco. The micro-cap company, valued at approximately $57 million, maintains a GOOD overall financial health score according to InvestingPro metrics.
Additionally, Orozco acquired 2,327 shares of common stock through the conversion of restricted stock units on March 7, with these transactions valued at $0 per share. Following these transactions, Orozco holds 12,008 shares of NeueHealth common stock. Investors anticipating the company’s next earnings report on March 20 can access additional insights and 12 more exclusive ProTips through InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.